A Phase 2 trial by Metabolic Pharmaceuticals found that while the compound was well-tolerated, it did not produce statistically significant weight loss versus placebo at the doses tested
I believe these medications have such broad effects because a lot of health problems begin with disruptions in insulin resistance [abnormalities in how the body handles glucose] and inflammation, says Jamy Ard, MD, a professor of epidemiology and prevention at Wake Forest University School of Medicine in Winston-Salem, North Carolina
Pharmaceutical companies typically resist early settlements in mass tort litigation, preferring to test their defenses at trial before committing to compensation frameworks
It couldve easily gone too playful, but it sounds like they held the line on credibility at the same time
[DOI] [PubMed] [Google Scholar] 130
What happens if you skip the escalation Jumping straight to a high dose is tempting but counterproductive